Oral administration of growth hormone (GH) releasing peptide-mimetic MK- 677 stimulates the GH/insulin-like growth factor-I axis in selected GH- deficient adults

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 10, 1997, Pages 3455-3463

  Chapman, Ian M ^a   Pescovitz, Ora H ^b   Murphy, Gail ^c   Treep, Theresa ^b   Cerchio, Kristine A ^c   Krupa, David ^c   Gertz, Barry ^c   Polvino, William J ^c   Skiles, Emily H ^a   Pezzoli, Suzan S ^a   Thorner, Michael O ^a,d  

^a UNIVERSITY OF VIRGINIA   (United States)

^b INDIANA UNIVERSITY   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

^d UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; IBUTAMOREN; INSULIN; PLACEBO; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET RESTRICTION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG INDUCED DISEASE; DRUG SCREENING; GLUCOSE BLOOD LEVEL; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INSULIN BLOOD LEVEL; MALE; ORAL DRUG ADMINISTRATION; POSTPRANDIAL STATE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; BLOOD GLUCOSE; CIRCADIAN RHYTHM; DOUBLE-BLIND METHOD; HORMONES; HUMAN GROWTH HORMONE; HUMANS; INDOLES; INSULIN; INSULIN-LIKE GROWTH FACTOR I; OLIGOPEPTIDES; OSMOLAR CONCENTRATION; SPIRO COMPOUNDS; TREATMENT OUTCOME;

EID: 9844226786     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.10.3455     Document Type: Article

References (42)

1. Salomon F, Cuneo RC, Hesp R, Sonksen PH. 1989 The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med. 321:1797-1803.
2. Rudman D, Feller AG, Nagraj HS, et al. 1990 Effects of human growth hormone in men over 60 years old. N Engl J Med. 323:1-6.
3. de Boer H, Blok GJ, Voerman HJ, Phillips M, Schouten JA. 1994 Serum lipid levels in growth hormone-deficient men. Metabolism. 43:199-203.
4. Rosen T, Eden S, Larson G, Wilhelmsen L, Bengtsson BA. 1993 Cardiovascular risk factors in adult patients with growth hormone deficiency. Acta Endocrinol (Copenh). 129:195-200.
5. Markussis V, Beshyah SA, Fisher C, Sharp P, Nicolaides AN, Johnston DG. 1992 Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults [see comments]. Lancet. 340:1188-1192.
6. Rosen T, Bengtsson BA. 1990 Premature mortality due to cardiovascular disease in hypopituitarism. Lancet. 336:285-288.
7. Bowers CY, Alster DK, Frentz JM. 1992 The growth hormone-releasing activity of a synthetic hexapeptide in normal men and short statured children after oral administration. J Clin Endocrinol Metab. 74:292-298.
8. Penalva A, Carballo A, Pombo M, Casaneuva FF, Dieguez C. 1993 Effect of growth hormone (CH)-releasing hormone (GURH), atropine, pyridostigmine, or hypoglycemia on GHRP-6-indueed GH secretion in man. J Clin Endocrinol Metab. 76:168-171.
9. Bowers CY, Momany FA, Reynolds GA, Hong A. 1984 On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology. 114:1537-1545.
10. Ilson BE, Jorkasky DK, Curnow RT, Stote RM. 1989 Effect of a new synthetic hexapeptide to selectively stimulate growth hormone release in healthy human subjects. J Clin Endocrinol Metab. 69:212-214.
11. Bowers CY, Sartor AO, Reynolds GA, Badger TM. 1991 On the actions of the growth hormone-releasing hexapeptide, GHRP. Endocrinology. 128:2027-2035.
12. Dickson SL, Leng G, Robinson ICAF. 1993 Systemic administration of growth hormone-releasing peptide activates hypothalamic arcuate neurons. Neurosci Lett. 53:303-306.
13. Popovic V, Damjanovic S, Micic D, Djurovic M, Dieguez C, Casanueva FF. 1995 Blocked growth hormone-releasing peptide (GHRP-6)-induced GH secretion and absence of the synergic action of GHRP-6 plus GH-releasing hormone in patients with hypothalamopituitary disconnection: evidence that GHRP-6 main action is exerted at the hypothalamic level. J Clin Endocrinol Metab. 80:942-947.
14. Hartman ML, Farello G, Pezzoli SS, Thorner MO. 1992 Oral administration of growth hormone (GH)-releasing peptide (GHRP) stimulates GH secretion in normal men. J Clin Endocrinol Metab. 74:1378-1384.
15. Gertz BJ, Barrett JS, Eisenhandler R, et al. 1993 Growth hormone response in man to L-692,429, a novel nonpeptide mimic of growth hormone releasing peptide (GHRP-6). J Clin Endocrinol Metab. 77:1393-1397.
16. Aloi JA, Gertz BJ, Hartman ML, et al. 1994 Neuroendocrine responses to a novel growth hormone secretagogue, L-692,429, in healthy older subjects [see comments]. J Clin Endocrinol Metab. 79:943-949.
17. Chapman IM, Hartman ML, Pezzoli SS, Thorner MO. 1996 Enhancement of pulsatile growth hormone secretion by continuous infusion of a growth hormone-releasing peptide mimetic, L-692,429, in older adults - a clinical research center study. J Clin Endocrinol Metab. 81:2874-2880.
18. Thorner MO, Rochiccioli P, Colle M, et al. 1996 Once daily subcutaneous growth hormone-releasing hormone therapy accelerates growth in growth hormone-deficient children during first year of therapy. J Clin Endocrinol Metab. 81:1189-1196.
19. Chapman IM, Hartman ML, Straume M, Johnson ML, Veldhuis JD, Thorner MO. 1994 Enhanced sensitivity growth hormone (GH) chemiluminescence assay reveals lower postglucose nadir GH concentrations in men than women. J Clin Endocrinol Metab. 78:1312-1319.
20. Veldhuis JD, Johnson ML. 1986 Cluster analysis: a simple, versatile, and robust algorithm for endocrine pulse detection. Am J Physiol. 250:E486-E493.
21. Arrigo T, Martino F, Lombardo F, et al. 1992 Diagnostic value of growth hormone-releasing hormone test in children and adolescents with idiopathic growth hormone deficiency. Eur J Pediatr. 151:263-265.
22. Lanes R, Carrillo E. 1994 Long-term therapy with a single daily subcutaneous dose of growth hormone releasing hormone (1-29) in prepubertal growth hormone deficient children. Venezuelan Collaborative Study Group. J Pediatr Endocrinol. 7:303-308.
23. Duck SC, Schwarz HP, Costin G, et al. 1992 Subcutaneous growth hormone-releasing hormone therapy in growth hormone-deficient children: first year of therapy. J Clin Endocrinol Metab. 75:1115-1120.
24. Smith RG, Cheng K, Schoen WR, et al. 1993 A nonpeptidyl growth hormone secretagogue. Science. 260:1640-1643.
25. Chaung LYP, Pong SS, Dean D, Schaeffer JM, Smith RG. 1996 Characterization of a G-protein-linked receptor for peptidyl and nonpeptidyl growth hormone secretagogue in rat and porcine hypothalamic and pituitary membranes. Program of the 10th International Congress on Endocrinology, San Francisco, CA; P1-613:288 (Abstract).
26. Pong SS, Chaung LYP, Dean DC, Nargund RP, Patchett AA, Smith RG. 1996 Identification of a new G-protein-linked receptor for growth hormone secretagogues. Mol Endocrinol. 10:57-61.
27. Wu D, Chen C, Zhang J, Katoh K, Clarke I. 1994 Effects in vitro of new growth hormone releasing peptide (GHRP-1) on growth hormone secretion from ovine pituitary cells in primary culture. J Neuroendocrinol. 6:185-190.
28. Cheng K, Chan WW, Butler B, Barreto, Jr, A, Smith RG. 1991 Evidence for a role of protein kinase-C in His-D-Trp-Ala-Trp-D-Phe-Lys-NH2-induced growth hormone release from rat primary pituitary cells. Endocrinology. 129:3337-3342.
29. Adams EF, Petersen B, Lei T, Buchfelder M, Fahlbusch R. 1995 The growth hormone secretagogue, L-692,429, induces phosphatidylinositol hydrolysis and hormone secretion by human pituitary tumors. Biochem Biophys Res Commun. 208:555-561.
30. Smith RG. 1996 Modulation of pulsatile growth hormone release by an orally active growth hormone secretagogue. Program of the 10th International Congress on Endocrinology, San Francisco, CA; S10-1:26 (Abstract).
31. Howard AD, Feighner SD, Cully DF, et al. 1996 A receptor in pituitary and hypothalamus that functions in growth hormone release [see comments]. Science. 273:974-977.
32. Bowers CY, Reynolds GA, Durham D, Barrera CM, Pezzoli SS, Thorner MO. 1990 Growth hormone (GH)-releasing peptide stimulates GH release in normal men and acts synergistically with GH-releasing hormone. J Clin Endocrinol Metab. 70:975-982.
33. Dickson SL, Leng G, Dyball RE, Smith RG. 1995 Central actions of peptide and non-peptide growth hormone secretagogues in the rat. Neuroendocrinology. 61:36-43.
34. Guillaume V, Magnan E, Cataldi M, et al. 1994 Growth hormone (GH)-releasing hormone secretion is stimulated by a new GH-releasing hexapeptide in sheep. Endocrinology. 135:1073-1076.
35. Chapman IM, Bach MA, Van Cauter E, et al. 1996 Stimulation of the growth hormone (GH)-insulin-like growth factor I axis by daily oral administration of a GH secretagogue (MK-677) in healthy elderly subjects. J Clin Endocrinol Metab. 81:4249-4257.
36. Hartman ML, Clayton PE, Johnson ML, et al. 1993 A low dose euglycemic infusion of recombinant human insulin-like growth factor I rapidly suppresses fasting-enhanced pulsatile growth hormone secretion in humans. J Clin Invest. 91:2453-2462.
37. Bermann M, Jaffe CA, Tsai W, DeMott-Friberg R, Barkan AL. 1994 Negative feedback regulation of pulsatile growth hormone secretion by insulin-like growth factor I. Involvement of hypothalamic somatostatin. J Clin Invest. 94:138-145.
38. Berelowitz M, Szabo M, Frohman LA, Firestone S, Chu L, Hintz RL. 1981 Somatomedin-C mediates growth hormone negative feedback by effects on both the hypothalamus and the pituitary. Science. 212:1279-1281.
39. Yamashita S, Melmed S. 1986 Insulin-like growth factor 1 action on rat anterior pituitary cells: suppression of growth hormone secretion and messenger ribonucleic acid levels. Endocrinology. 118:176-182.
40. Hickey GJ, Jacks T, Schleim K, et al. 1996 Repeat administration of the GH secretagogue MK-0677 increases and maintains elevated IGF-I levels in beagles. J Endocrinol. 152:183-192.
41. Giustina A, Scalvini T, Tassi C, et al. 1997 Maturation of the regulation of growth hormone secretion in young males with hypogonadotropic hypogonadism pharmacologically exposed to progressive increments in serum testosterone. J Clin Endocrinol Metab. 82:1210-1219.
42. Fowelin J, Attvall S, Lager I, Bengtsson BA. 1993 Effects of treatment with recombinant human growth hormone on insulin sensitivity and glucose metabolism in adults with growth hormone deficiency. Metabolism. 42:1443-1447.